Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-177.18M
↓ 29% below average
Average (9y)
$-137.73M
Historical baseline
Range
High:$703.98M
Low:$-427.65M
CAGR
+8.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-177.18M | +8.4% |
| 2023 | $-193.47M | +37.5% |
| 2022 | $-309.68M | +27.6% |
| 2021 | $-427.65M | -33.4% |
| 2020 | $-320.55M | +9.7% |
| 2019 | $-354.97M | -150.4% |
| 2018 | $703.98M | +881.4% |
| 2017 | $-90.09M | +27.0% |
| 2016 | $-123.42M | -46.4% |
| 2015 | $-84.28M | - |